Harel Insurance Investments & Financial Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,250
| Closed | -$35K | – | 474 |
|
2025
Q1 | $35K | Sell |
1,250
-13,750
| -92% | -$385K | ﹤0.01% | 391 |
|
2024
Q4 | $624K | Buy |
+15,000
| New | +$624K | 0.01% | 147 |
|
2024
Q3 | – | Sell |
-11,190
| Closed | -$1.36M | – | 543 |
|
2024
Q2 | $1.36M | Buy |
+11,190
| New | +$1.36M | 0.03% | 147 |
|
2024
Q1 | – | Sell |
-720
| Closed | -$71K | – | 601 |
|
2023
Q4 | $71K | Hold |
720
| – | – | ﹤0.01% | 391 |
|
2023
Q3 | $72K | Sell |
720
-9,160
| -93% | -$916K | ﹤0.01% | 415 |
|
2023
Q2 | $1.21M | Sell |
9,880
-13,163
| -57% | -$1.61M | 0.03% | 131 |
|
2023
Q1 | $3.4M | Buy |
23,043
+10,262
| +80% | +$1.51M | 0.07% | 109 |
|
2022
Q4 | $2.28M | Buy |
+12,781
| New | +$2.28M | 0.05% | 122 |
|
2022
Q2 | – | Sell |
-140
| Closed | -$24K | – | 774 |
|
2022
Q1 | $24K | Sell |
140
-10,264
| -99% | -$1.76M | ﹤0.01% | 619 |
|
2021
Q4 | $2.61M | Buy |
10,404
+8,518
| +452% | +$2.14M | 0.05% | 111 |
|
2021
Q3 | $726K | Sell |
1,886
-1,308
| -41% | -$504K | 0.02% | 186 |
|
2021
Q2 | $2.45M | Sell |
3,194
-2,394
| -43% | -$1.83M | 0.05% | 174 |
|
2021
Q1 | $2.45M | Buy |
5,588
+1,579
| +39% | +$691K | 0.05% | 220 |
|
2020
Q4 | $1.35M | Sell |
4,009
-712
| -15% | -$239K | 0.03% | 245 |
|
2020
Q3 | $334K | Sell |
4,721
-279
| -6% | -$19.7K | 0.01% | 237 |
|
2020
Q2 | $321K | Buy |
5,000
+3,900
| +355% | +$250K | 0.01% | 183 |
|
2020
Q1 | $33K | Buy |
+1,100
| New | +$33K | ﹤0.01% | 298 |
|
2019
Q4 | – | Sell |
-386
| Closed | -$6K | – | 530 |
|
2019
Q3 | $6K | Buy |
+386
| New | +$6K | ﹤0.01% | 466 |
|